Amit Lahoti, M.D.
Department of Emergency Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Professor, Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1998 | University of Texas Medical School at San Antonio, San Antonio, Texas, US, MD |
| 1994 | University of Texas at Austin, Austin, Texas, US, Biology, BA |
Postgraduate Training
| 2008-2012 | Master's in Clinical Research Program, The University of Texas Medical School at Houston, Houston, Texas |
| 2004-2006 | Clinical Fellowship, Nephrology, University of Texas Medical School at Houston, Houston, Texas |
| 2002-2004 | Hospitalist, Hospitalist, Kelsey-Seybold Clinic, Houston, Texas |
| 2001-2002 | General Internist, Macgregor Medical Association, Houston, Texas |
| 1998-2001 | Clinical Residency, Internal Medicine, University of Texas Medical School at Houston, Houston, Texas |
Licenses & Certifications
| 2006 | American Board of Internal Medicine-Nephrology |
| 2002 | American Board of Internal Medicine-Internal Medicine |
| 1998 | Texas Medical License |
| null | Florida Board of Medicine |
| null | Washington State Department of Health |
| null | Louisiana State Board of Medical Examiners |
| null | Mississippi State Board of Medical Licensure |
| null | Oklahoma State Board of Medical Licensure |
| null | Alabama Board of Medical Examiners |
| null | Georgia Composite Medical Board |
| null | Tennessee Board of Medical Examiners |
| null | Arizona Board of Medical Examiners |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Internal Medicine, Baylor College of Medicine, Houston, TX, 2014 - 2026
Associate Professor, Department of Internal Medicine, Baylor College of Medicine, Houston, TX, 2014 - 2025
Associate Professor, Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2021
Instructor, Internal Medicine, The University of Texas Medical School at Houston, Houston, TX, 2007 - 2024
Assistant Professor, Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Administrative Appointments/Responsibilities
Patient Experience Officer for Mays IMC, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Patient Safety Quality Officer for Nephrology, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, 2021 - Present
Education Director (Division level), Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2021
Baylor College of Medicine Nephrology Fellowship Rotation Site Director, Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2021
Patient Safety Quality Officer for Nephrology, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2019
Baylor College of Medicine Internal Medicine Residency Rotation Site Director, Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2023
Onconephrology Fellowship Associate Program Director, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
UT Health Nephrology Fellowship Rotation Site Director, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2021
Section Chief of Nephrology ad interim, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2013
Other Professional Positions
Outpatient Clinic Director for Nephrology, MD Anderson Cancer Center, Houston, TX, 2022 - Present
Patient Safety Quality Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Dialysis QAPI Workgroup, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Extramural Institutional Committee Activities
Chair, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Co-Chair, GU Medical Oncology Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Vice Chair, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Member, Medical Practice Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Chair, GME Institutional Review Subcommittee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, GME Institutional Review Subcommittee, The University of Texas MD Anderson Cancer Center, 2012 - 2019
Voting Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2015
Member, Clinical Research Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2011
Member, Diabetes Workgroup Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2007
Editorial Activities
Review Editor, Onconephrology, 2021 - Present
Honors & Awards
| 2018 | Faculty Excellence Award in Education Nominee, UT MD Anderson Cancer Center |
| 2017 | President's Recognition for Faculty Excellence, UT MD Anderson Cancer Center |
| 2016 | Baylor House Staff Teaching Faculty Award, Baylor College of Medicine Department of Internal Medicine |
| 2014 | Clinician Leader of the Year, Division of Internal Medicine |
| 2013 - 2016 | Faculty Scholar Award (3-year award), UT MD Anderson Cancer Center |
| 2010 | Cyrus Scholar Award Semi-Finalist, UT MDACC, The Division of Internal Medicine Research Retreat |
| 2008 | Cyrus Scholar Award Finalist, UT MDACC, The Division of Internal Medicine Research Retreat |
| 2008 | Research Citation Finalist, Society of Critical Care Medicine 37th Critical Care Congress |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Reducing Time to Next Available Consult in the Nephrology Clinic. Invited. Division of Internal Medicine Grand Rounds. Houston, Texas, US.
- 2024. Update on Multiple Myeloma and the Kidney. Invited. Onconephrology Fellow/APP Lecture Series. Houston, Texas, US.
- 2023. An Initiative to Decrease Transport Time to Dialysis. Invited. Division of Internal Medicine Grand Rounds. Houston, Texas, US.
- 2016. Multiple Myeloma and the Kidney. Conference. UT MD Anderson. Houston, TX, US.
- 2013. Update in Renal Replacement Therapy. Conference. Texas Society of Critical Care Medicine. Houston, TX, US.
- 2013. End Stage Renal Disease for the Primary Care Physician Assistant. Conference. Texas Association of Physician Assistants. Houston, TX, US.
- 2012. Diagnosing AKI: Past, Present, Future. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 2011. Renal Issues in Anesthesiology. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2010. Acute Kidney Injury in Leukemia Patients. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2009. Stem Cell Transplant and Kidney Injury: M.D. Anderson Experience. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2009. Renal Disease in Hematopoietic Cell Transplant. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2008. Acute Kidney Injury as defined by the RIFLE Classification has Prognostic Utility in Critically Ill Patients with Cancer. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2008. Myeloma Kidney Disease. Conference. UT Medical School at Houston. Houston, TX, US.
- 2006. Acute Kidney Injury: What is New?. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
National Presentations
- 2020. Cancer Screening in Dialysis Patients. Invited. American Society of Nephrology. Denver, CO, US.
- 2018. Multiple Myeloma and the Kidney. Invited. UT MD Anderson Cancer Center. Houston, TX, US.
- 2017. Acute renal failure and hyperkalemia. Invited. 2nd Annual MD Anderson Oncologic Emergency Medicine Conference. Houston, TX, US.
- 2015. Metabolic Complications in the Cancer Patient. Invited. 1st Annual MD Anderson Oncologic Emergency Medicine Conference. Houston, TX, US.
- 2008. Acute Kidney Injury as Defined by the RIFLE Classification Has Prognostic Utility in Critically Ill Patients With Cancer/Awarded Research Citation Finalist for 2008. Conference. 37th Critical Care Congress/2008. Honolulu, HI, US.
International Presentations
- 2017. Multiple Myeloma and the Kidney. Invited. Menarini International Foundation. Naples, IT.
Selected Publications
Peer-Reviewed Articles
- Manzullo, EF, Faiz, S, Hamill, RJ, Tweardy, D, Sembera, CA, Lahoti, A, Odaro, OE. BCM-MD Anderson onco-medicine track. Supportive Care in Cancer 34(1), 2026. e-Pub 2026. PMID: 41413680.
- Mamlouk O, Selamet U, Machado S, Abdelrahim M, Glass WF, Tchakarov A, Gaber L, Lahoti A, Workeneh B, Chen S, Lin J, Abdel-Wahab N, Tayar J, Lu H, Suarez-Almazor M, Tannir N, Yee C, Diab A, Abudayyeh A. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. J Immunother Cancer 7(1):2, 2019. e-Pub 2019. PMID: 30612580.
- Aria AB, Chen L, Glass WF, Lahoti A, Chon SY. Leukocytoclastic vasculitis with late-onset Henoch-Schönlein purpura after trifluridine/tipiracil treatment. Dermatol Online J 24(10), 2018. e-Pub 2018. PMID: 30677817.
- Cortes JE, Gambacorti-Passerini C, Kim DW, Kantarjian HM, Lipton JH, Lahoti A, Talpaz M, Matczak E, Barry E, Leip E, Brümmendorf TH, Khoury HJ. Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias. Clin Lymphoma Myeloma Leuk 17(10):684-695, 2017. e-Pub 2017. PMID: 28807791.
- Lahoti A, Glass WF. Multiple myeloma and kidney disease. Journal of Onco-nephrology 1(2):95-102, 2017. e-Pub 2017.
- Doshi M, Lahoti A, Danesh FR, Batuman V, Sanders PW, Onco-Nephrology Forum ASON. Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?. Clin J Am Soc Nephrol 11(12):2288-2294, 2016. e-Pub 2016. PMID: 27526707.
- Saunders IM, Lahoti A, Chemaly RF, Trevino C, Westmoreland M, Hosing C. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. J Oncol Pharm Pract 22(2):325-31, 2016. e-Pub 2016. PMID: 25488905.
- Lan J, Lahoti A, Lew DB. A severe case of minocycline-induced DRESS resulting in liver transplantation and autoimmune sequelae. Ann Allergy Asthma Immunol 116(4):367-8, 2016. e-Pub 2016. PMID: 26782675.
- Sasaki K, Lahoti A, Jabbour E, Jain P, Pierce S, Borthakur G, Daver N, Kadia T, Pemmaraju N, Ferrajoli A, O'Brien S, Kantarjian H, Cortes J. Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients with Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-existing Liver and/or Renal Dysfunction. Clin Lymphoma Myeloma Leuk 16(3):152-62, 2016. e-Pub 2016. PMID: 26796981.
- Yilmaz M, Lahoti A, O'Brien S, Nogueras-González GM, Burger J, Ferrajoli A, Borthakur G, Ravandi F, Pierce S, Jabbour E, Kantarjian H, Cortes JE. Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Cancer 121(21):3894-904, 2015. e-Pub 2015. PMID: 26217876.
- Abudayyeh AA, Lahoti A, Salahudeen AK. Onconephrology: the need and the emergence of a subspecialty in nephrology. Kidney Int 85(5):1002-4, 2014. e-Pub 2014. PMID: 24786870.
- Salahudeen AK, Ali N, George M, Lahoti A, Palla S. Tolvaptan in hospitalized cancer patients with hyponatremia: A double-blind, randomized, placebo-controlled clinical trial on efficacy and safety. Cancer 120(5):744-51, 2014. e-Pub 2014. PMID: 24895288.
- Salahudeen AK, Doshi SM, Pawar T, Nowshad G, Lahoti A, Shah P. Incidence Rate, Clinical Correlates, and Outcomes of AKI in Patients Admitted to a Comprehensive Cancer Center. Clin J Am Soc Nephrol 8(3):347-54, 2013. e-Pub 2013. PMID: 23243268.
- Smith J, Murthy R, Lahoti A, Odisio B, Avritscher R, Chasen B, Mahvash A. Temporary Balloon Occlusion of the Common Hepatic Artery for Yttrium-90 Glass Microspheres Administration in a Patient with Hepatocellular Cancer and Renal Insufficiency. Case Rep Radiol 2013:560758, 2013. e-Pub 2013. PMID: 23710405.
- Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK. Hyponatremia in Hospitalized Cancer Patients and its Impact on Clinical Outcomes. Am J Kidney Dis 59(2):222-8, 2012. e-Pub 2012. PMID: 22001181.
- Raval M, Gulbis A, Bollard C, Leen A, Chemaly R, Shpall E, Lahoti A, Kebriaei P. Evaluation and Management of BK Virus-Associated Nephropathy Following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 17(11):1589-93, 2011. e-Pub 2011. PMID: 21767514.
- Lahoti A, Nates JL, Wakefield CD, Price KJ, Salahudeen AK. Costs and outcomes of acute kidney injury in critically ill patients with cancer. J Support Oncol 9(4):149-55, 2011. e-Pub 2011. PMID: 21809520.
- Lahoti A, Kantarjian H, Salahudeen AK, Ravandi F, Cortes JE, Faderl S, O'Brien S, Wierda W, Mattiuzzi GN. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer 116(17):4063-8, 2010. e-Pub 2010. PMID: 20564156.
- Salahudeen AK, Kumar V, Madan N, Xiao L, Lahoti A, Samuels J, Nates J, Price K. Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol (8):1338-46(8):1338-46, 2009. e-Pub 2009. PMID: 19628685.
- Parikh GC, Amjad AI, Saliba RM, Kazmi SM, Khan ZU, Lahoti A, Hosing C, Mendoza F, Qureshi SR, Weber DM, Wang M, Popat U, Alousi AM, Champlin RE, Giralt SA, Qazilbash MH. Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma. Biol Blood Marrow Transplant (7):812-6(7):812-6, 2009. e-Pub 2009. PMID: 19539212.
Professional Educational Materials
- Lahoti A. Section of Nephrology Fellows Syllabus. MD Anderson Cancer Center, Section of Nephrology, 2006.
- Lahoti A. Acute Renal Failure: Questions and Answers. Patient Education Online, 2006.
- Lahoti A. Chronic Kidney Disease: Questions and Answers. Patient Education Online, 2006.
- Lahoti A, Humphreys B. AKI Associated with Malignancies. American Society of Nephrology Online Curricula: Onco-Nephrology.
- Lahoti A. AKI in Cancer Patients. American Society of Nephrology Online Curricula: Onco-Nephrology.
Abstracts
- Mauiyyedi S, Lahoti A, Tchakarov A. Glomerular Intracytoplasmic Vacuolization in a Patient Receiving Polyethylene Glycol Biopharmaceutical. Journal of the American Society of Nephrology 35(Abstract Issue):754, 2024. e-Pub 2024.
- Ratnani P, Mamlouk O, Lahoti, A, Al Shaarani M. Paraneoplastic Membranoproliferative Glomerulonephritis Associated with Neoplasm Transformation. Journal of the American Society of Nephrology 34(Abstract Issue):789, 2023. e-Pub 2023.
- Abudayyeh A, Kalu C, Lakhani L, Workeneh B, Lahoti A, Chen S, Danesh F, Abdelrahim M. Incidence of AKI in a Large Retrospective Cancer Cohort Using Checkpoint Inhibitors. Journal of the American Society of Nephrology 29:1039, 2018. e-Pub 2018.
- Shang H, Mamlouk O, Bhattarai M, Lahoti A, Workeneh B, Glass W. Myeloma-Like Cast Nephropathy in a Patient with Pancreatic Mixed Acinar- Neuroendocrine Cancer. Journal of the American Society of Nephrology 29(Abstract Issue):793, 2018. e-Pub 2018.
- Ziaolhagh A, Ogbonnaya-Odor C, Teakell J, Lahoti A. Recurrent SIADH: A Rare Complication of Intrathecal Interleukin-2 Treatment for Melanoma with Brain Metastases. Journal of the American Society of Nephrology 28(Abstract Issue):395, 2017. e-Pub 2017.
- Selamet U, Ziaolhagh A, Makhani L, Lahoti A, Workeneh B, Tchakarov A, Glass W, Abudayyeh A. Nephrotoxicity of Immune Checkpoint Inhibitors: MD Anderson Cancer Center’s Experience. Journal of the American Society of Nephrology 28(Abstract Issue):404, 2017. e-Pub 2017.
- Kala J, Lahoti A, Abudayyeh A. Rare Cause of Granulomatous Acute Interstitial Nephritis. Journal of the American Society of Nephrology 27(Abstract Issue):381A, 2016. e-Pub 2016.
- Kala J, Lahoti A. Hyponatremia Is Common among Patients Receiving Stem Cell Transplant and Is an Independent Predictor of Mortality. Journal of the American Society of Nephrology 27(Abstract Issue):205A, 2016. e-Pub 2016.
- Kala J, Lahoti A. Anti-Thymocyte Globulin Induced Non Cardiogenic Pulmonary Edema. Journal of the American Society of Nephrology 26(Abstract Issue):983A, 2015. e-Pub 2015.
- Ali N, Palla S, George M, Lahoti A, Salahudeen A. Randomized, Double-Blind, Placebo-Controlled Trial of Tolvaptan in Cancer Patients with Hyponatremia: Preliminary Report. Journal of the American Society of Nephrology 23(Abstract Issue):994A, 2012. e-Pub 2012.
- Thomas E, Doshi S, Lahoti A, Salahudeen A. The Cost and Clinical Outcomes of Hypernatremia in Hospitalized Cancer Patients. Journal of the American Society of Nephrology 22(Abstract Issue):518A, 2011. e-Pub 2011.
- Lahoti A, Salahudeen AK. Predictors, Costs, and Outcomes of Acute Kidney Injury in Critically Ill Patients with Cancer. Journal of the American Society of Nephrology 21(Abstract Issue):124A, 2010. e-Pub 2010.
- Salahudeen AK, Lahoti A. Acute Kidney Injury in Cancer Patients: Incidence, Risk Factors, and Outcomes. Journal of the American Society of Nephrology 21(Abstract Issue):124A, 2010. e-Pub 2010.
- Lahoti A, Salahudeen AK. Acute Kidney Injury Occurs in a Significant Number of Patients Undergoing Stem Cell Transplant and is Associated with Decreased Survival. Journal of the American Society of Nephrology 21(Abstract Issue):124A, 2010. e-Pub 2010.
- Lahoti A, Salahudeen AK. Acute Kidney Injury as Defined by the RIFLE Classification Had Prognostic Utility in Critically Ill Patients with Cancer. Critical Care Medicine 35(12 Suppl):A240, 2007. e-Pub 2007.
- Lahoti A, Nates J, Samuels J, Wakefield CD, Price KJ, Salahudeen AK. RIFLE Criteria for Acute Kidney Injury Correlates with Hospital Mortality in Critically Ill Patients with Cancer. Journal of the American Society of Nephrology 18(Abstract Issue):959A, 2007. e-Pub 2007.
- Madan N, Kumar V, Lahoti A, Nates J, Price K, Salahudeen AK. Renal Replacement Therapy in Critically Ill Cancer Patients Using Continuous Sustained Low Efficiency Dialysis (C-SLED): Feasibility, Efficacy and Tolerability. Journal of the American Society of Nephrology 18(Abstract Issue):450A, 2007. e-Pub 2007.
Book Chapters
- Lahoti A, Chen S. Acute Kidney Injury: Incidence, Pathogenesis, and Outcomes. In: Onco-Nephrology. 1st. Elsevier, 270-274, 2020.
- Lahoti A. Renal Emergencies in Patients with Cancer. In: Oncologic Emergency Medicine: Principles and Practice. 2nd. Springer Nature, 2020.
- Lahoti A, Danesh F. Nephro-Urologic Emergencies in Patients With Cancer. In: Oncologic Emergency Medicine: Principles and Practice. 1st. Springer, 273-284, 2016.
- Lahoti A, Cruz-Carreras MT, Salahudeen AK. Nephro-urological Emergencies in Patients with Cancer. In: Oncologic Emergencies. 1st. Springer Verlag, 143-160, 2016.
- Sachdeva M, Lahoti A, Mathew A. Chronic Kidney Disease in Cancer Patients. In: Onco-Nephrology: Cancer, Chemotherapy and the Kidney. 1st. Springer, 2015.
- Lahoti A. Multiple Myeloma and Kidney Disease. In: Renal Disease in Cancer Patients. 1st. Academic Press, 2013.
- Busaidy NL, Lahoti A, Hanley DA. Secondary Hyperparathyroidism. In: Handbook of Parathyroid Diseases: A Case-Based Practical Guide. Springer, 141-158, 2012.
- Finkel KW, Lahoti A, Foringer JR. Renal Disease in Cancer Patients. In: Brenner and Rector's The Kidney. 9th. Saunders, 1536-1554, 2012.
Patient Reviews
CV information above last modified July 22, 2026